Stock Research for ANTH

ANTH

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ANTH Stock Chart & Research Data

The ANTH chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ANTH chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ANTH Due diligence Resources & Stock Charts

The ANTH stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ANTH Detailed Price Forecast - CNN Money CNN View ANTH Detailed Summary - Google Finance
Yahoo View ANTH Detailed Summary - Yahoo! Finance Zacks View ANTH Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ANTH Trends & Analysis - Trade-Ideas Barrons View ANTH Major Holders - Barrons
NASDAQ View ANTH Call Transcripts - NASDAQ Seeking View ANTH Breaking News & Analysis - Seeking Alpha
Spotlight View ANTH Annual Report - CompanySpotlight.com OTC Report View ANTH OTC Short Report - OTCShortReport.com
TradeKing View ANTH Fundamentals - TradeKing Charts View ANTH SEC Filings - Bar Chart
WSJ View Historical Prices for ANTH - The WSJ Morningstar View Performance/Total Return for ANTH - Morningstar
MarketWatch View the Analyst Estimates for ANTH - MarketWatch CNBC View the Earnings History for ANTH - CNBC
StockMarketWatch View the ANTH Earnings - StockMarketWatch MacroAxis View ANTH Buy or Sell Recommendations - MacroAxis
Bullish View the ANTH Bullish Patterns - American Bulls Short Pains View ANTH Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ANTH Stock Mentions - StockTwits PennyStocks View ANTH Stock Mentions - PennyStockTweets
Twitter View ANTH Stock Mentions - Twitter Invest Hub View ANTH Investment Forum News - Investor Hub
Yahoo View ANTH Stock Mentions - Yahoo! Message Board Seeking Alpha View ANTH Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ANTH - SECform4.com Insider Cow View Insider Transactions for ANTH - Insider Cow
CNBC View ANTH Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ANTH - OTC Markets
Yahoo View Insider Transactions for ANTH - Yahoo! Finance NASDAQ View Institutional Holdings for ANTH - NASDAQ


Stock Charts

FinViz View ANTH Stock Insight & Charts - FinViz.com StockCharts View ANTH Investment Charts - StockCharts.com
BarChart View ANTH Stock Overview & Charts - BarChart Trading View View ANTH User Generated Charts - Trading View




Latest Financial News for ANTH


Anthera Pharma and Three Additional Stocks Under Scanner in the Biotech Space
Posted on Friday June 29, 2018

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on ANTH sign up now at www.wallstequities.com/registration. The nature of the operations of firms in the Biotech industry makes equities in this space more suited to aggressive, risk-tolerant investors.


Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut
Posted on Thursday June 28, 2018

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 27) Aptinyx Inc (NASDAQ: APTX ) Cardiovascular Systems Inc (NASDAQ: ...


Anthera Pharma Stock Plunged 53% Today, ANTH Suspended Tomorrow
Posted on Wednesday June 27, 2018

Today, Anthera Pharmaceuticals (ANTH) registered a stock price decline of ~53% on news that the stock will be suspended from trading on the NASDAQ Capital Market at the start of business tomorrow. Following the delisting, Anthera Pharmaceuticals’ securities will be listed on the OTC Market. If the company requires its stock to trade on another trading platform, it may take the necessary steps.


Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading of its Securities on the NASDAQ Capital Markets
Posted on Wednesday June 27, 2018

Anthera Pharmaceuticals, Inc. (ANTH) (“Anthera” or the “Company”) announced today that it has withdrawn its request for a hearing to appeal the delisting determination of the Staff of the Nasdaq Stock Market (“Nasdaq”) from the Nasdaq Capital Market. The Nasdaq Staff has accepted the Company’s withdrawal and will suspend the trading of the Company’s securities at the open of business on June 28, 2018.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.